1,529
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Vaginal microecological changes of different degrees of cervical lesions in Hakka women in Meizhou City

, , , , , , , , , , & show all
Article: 2186780 | Received 15 Dec 2022, Accepted 27 Feb 2023, Published online: 20 Mar 2023

References

  • Arbyn, M., et al., 2020. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health, 8 (2), e191–e203.
  • Audirac-Chalifour, A., et al., 2016. Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study. PLoS One, 11 (4), e0153274.
  • Bik, E.M., et al., 2019. A novel sequencing-based vaginal health assay combining self-sampling, HPV detection and genotyping, STI detection, and vaginal microbiome analysis. PLoS One, 14 (5), e0215945.
  • Bizzarri, N., et al., 2021. Peritoneal HPV-DNA test in cervical cancer (PIONEER study): a proof of concept. International Journal of Cancer, 148 (5), 1197–1207.
  • Brotman, R.M., et al., 2014. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. Journal of Infectious Diseases, 210 (11), 1723–1733.
  • Colombo, N., et al., 2012. Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 23 (Suppl 7), vii27–vii32.
  • Dellino, M., et al., 2022. Lactobacillus crispatus M247 oral administration: Is it really an effective strategy in the management of papillomavirus-infected women? Infect Agent Cancer, 17, 53.
  • Derks, M., et al., 2018. Surgical treatment of early-stage cervical cancer: a multi-institution experience in 2124 cases in The Netherlands over a 30-year Period. International Journal of Gynecologic Cancer, 28 (4), 757–763.
  • He, R.Y., et al., 2012. The research of health management for prevention and treatment of cervical persistent high-risk HPV Infection. Clinical Medicine & Engineering, 8, 89–92.
  • Horn, L.C., et al., 2019. Prognostic relevance of low-grade versus high-grade FIGO IB1 squamous cell uterine cervical carcinomas. Journal of Cancer Research and Clinical Oncology, 145 (2), 457–462.
  • Human Microbiome Project C. 2012. Structure, function and diversity of the healthy human microbiome. Nature, 486, 207–214.
  • Kovachev, S.M., 2020. Cervical cancer and vaginal microbiota changes. Archives of Microbiology, 202 (2), 323–327.
  • Lee, J.E., et al., 2013. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One, 8 (5), e63514.
  • Li, C., et al., 2022. Changes in the cervicovaginal microbiota composition of HPV16-infected patients after clinical treatment. Cancer Medicine, 11 (24), 5037–5049.
  • Li, D., et al., 2020. Vaginal microbiome analysis of healthy women during different periods of gestation. Bioscience Reports., 40, BSR20201766.
  • Martin, D.H., 2012. The microbiota of the vagina and its influence on women’s health and disease. American Journal of the Medicine Science, 343 (1), 2–9.
  • Masson, L., et al., 2019. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study. Sexually Transmitted Infections, 95 (1), 5–12.
  • Meijer, C.J. and Snijders, P.J., 2014. Cervical cancer in 2013: screening comes of age and treatment progress continues. Nature Reviews Clinical Oncology, 11 (2), 77–78.
  • Mitra, A., et al., 2016. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome, 4 (1), 58.
  • Palma, E., et al., 2018. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection. BMC Infectious Diseases, 18 (1), 13.
  • Ravel, J., et al., 2011. Vaginal microbiome of reproductive-age women. Proceedings of the National Academy of Sciences, 108 (supplement_1), 4680–4687.
  • Seo, S.S., et al., 2016. Combined effect of diet and cervical microbiome on the risk of cervical intraepithelial neoplasia. Clinical Nutrition, 35 (6), 1434–1441.
  • Smith, J.S., et al., 2003. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet, 361 (9364), 1159–1167.
  • Sodhani, P., et al., 2017. Bacterial vaginosis and cervical intraepithelial neoplasia: is there an association or is co-existence incidental? Asian Pacific Journal of Cancer Prevention, 18 (5), 1289–1292.
  • Sung, H., et al., 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. A Cancer Journal for Clinicians, 71 (3), 209–249.
  • Valenti, G., et al., 2017. Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice? Updates in Surgery, 69 (4), 441–449.
  • Xu, B., et al., 2021. Bacterial diterpene synthases prenylate small molecules. ACS Catalysis, 11 (10), 5906–5915.
  • Yang, L., et al., 2018. Hypoxia-induced miR-214 expression promotes tumour cell proliferation and migration by enhancing the Warburg effect in gastric carcinoma cells. Cancer Letters, 414, 44–56.
  • Yang, Y., et al., 2021. Lipid metabolism regulator human hydroxysteroid dehydrogenase-like 2 (HSDL2) modulates cervical cancer cell proliferation and metastasis. Journal of Cellular and Molecular Medicine, 25 (10), 4846–4859.